Biological studies of radiolabeled glucose analogues iodinated in positions 3, 4 or 6

Nuclear Medicine and Biology

Volumn 31, Issue 2, 2004, Pages 241-250

  Perret, Pascale ^a   Ghezzi, Catherine ^a   Ogier, Lionel ^b   Abbadi, Medhi ^b   Morin, Christophe ^b   Mathieu, Jean Paul ^a   Fagret, Daniel ^a  

^a French Clinical Research Infrastructure Network   (France)

^b UNIVERSITÉ JOSEPH FOURIER   (France)

Author keywords

Glucose uptake; Iodinated glucose analogues; Radiopharmaceuticals; SPECT

Indexed keywords

DEOXYGLUCOSE; GLUCOSE DERIVATIVE; IODINE 123; IODINE 125;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; RADIOIODINATION; RAT;

ADIPOCYTES; ANIMALS; CELLS, CULTURED; ERYTHROCYTES; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; MALE; METABOLIC CLEARANCE RATE; MICE; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 1542285451     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2003.08.009     Document Type: Article

References (35)

1. Schelbert H.R., Buxton D. Insights into coronary disease gained from metabolic imaging. Circulation. 78:1988;496-505.
2. Garvey W.T., Birnbaum M.J. Cellular insulin action and insulin resistance. Ferrannini E. Bailleiere's clinical endocrinology and metabolism Insulin resistance and disease. 1994;785-873 Bailleiere Tindall, London.
3. Rigo P., Paulus P., Kaschten B.J., Hustinx R., Bury T., Jerusalem G., Benoit T., Foidart-Willems J. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 23:1996;1641-1674.
4. Weber M.J., Salter D.W., McNair T.E. Increased glucose transport in malignant cells analysis of its molecular basis. Arnott M.S., Van Eys J., Wang Y.-M. Molecular interrelations of nutrition and cancer. 1982;183-190 Raven Press, New York.
5. Opie L.H., Hesse B. Radionuclide tracers in the evaluation of resting myocardial ischaemia and viability. Eur J Nucl Med. 24:1997;1183-1193.
6. Ishii K., Sasaki M., Kitagaki H., Yamaji S., Sakamoto S., Matsuda K., Mori E. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med. 38:1997;925-928.
7. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose Validation of method. Ann Neurol. 6:1979;371-388.
8. Delbeke D. Oncological applications of FDG PET imaging brain tumors, colorectal cancer lymphoma and melanoma. J Nucl Med. 40:1999;591-603.
9. Goodman M.M., Kabalka G.W., Waterhouse R.N., Daniel G.B. Synthesis of iodine-123 labeled 3-0-(E)-3-iodopropen-2-yl-D-glucose a potential new agent for the assessment of glucose transport into the brain and heart using SPECT. J Labelled Compd Radiopharm. 30:1991;278-279.
10. Goodman M.M., Kabalka G.W., Meng X. Synthesis of iodine-123 labeled 4-0-(E)-3-iodopropen-2-yl-2-deoxy-D-glucose and 4-0-(E)-3-iodopropen-2-yl-D- glucose as potential brain and heart imaging agents. J Labelled Compd Radiopharm. 30:1991;280-282.
11. 123I]-6-deoxy-6-iodo-D-glucose (6DIG), a potential tracer of glucose transport. Nucl Med Biol. 24:1997;527-534.
12. 123I. J Labelled Compd Radiopharm. 20:1983;391-415.
13. 123I-analogues of D-glucose as potential tracers for glucose utilization in heart and brain. Eur J Nucl Med. 8:1983;237-241.
14. Koumanov F., Henry C., Ghezzi C., Bignan G., Morin C., Mathieu J.-P., Hamant S., Vidal M., de Leiris J., Comet M. Biological studies of analogues of glucose iodinated in positions 1, 2, or 3. Nucl Med Biol. 23:1996;53-60.
15. Koumanov F., Henry C., Ghezzi C., Mathieu J.-P., Morin C., Vidal M., de Leiris J., Comet M. Biological evaluation of two anomeric glucose analogues iodinated in position 6. Nucl Med Biol. 24:1997;519-525.
16. 123I]-iodobenzyl)glucose. J Labelled Compd Radiopharm. 29:1991;535-545.
17. Magata Y., Saji H., Ohmomo Y., Tanaka C., Konishi J., Yokoyama A. Development of a novel radioiodinated glucose derivative with interaction to hexokinase. J Labelled Compd Radiopharm. 31:1992;317-328.
18. LeFevre P.G. Sugar transport in the red blood cell structure - activity relationships in substrates and antagonists. Physiol Rev. 13:1961;39-70.
19. Abbadi M., Mathieu J.-P., Morin C. A synthesis of 4-deoxy-D-glucose suitable for radiolabeling. J Labelled Compd Radiopharm. 39:1997;487-492.
20. Morin C., Ogier L. Synthesis of 4-O- and 6-O-(2′-iodoethyl)-D- glucose. Carbohydr Res. 310:1998;277-282.
21. Mathieu J.-P., Riche F., Coornaert S., Bardy A., Busquet G., Godart J., Comet M., Vidal M. Marquage d'acides gras en position ω par les isotopes de l'iode. J Biophys Med Nucl. 6:1982;233-237.
22. Levine M., Levine S., Jones M.N. The effect of temperature on the competitive inhibition of sorbose transfer in human erythrocytes by glucose. Biochim Biophys Acta Sci. 225:1971;291-300.
23. Henry C., Koumanov F., Ghezzi C., Mathieu J.-P., Hamant S., de Leiris J., Comet M. Experimental models, protocols and reference values for evaluation of iodinated analogues of glucose. Nucl Med Biol. 22:1995;875-885.
24. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 239:1964;375-380.
25. Dole V.P. The fatty acid pool in adipose tissue. J Biol Chem. 236:1961;3121-3124.
26. Sols A., Crane R.K. Substrate specificity of brain hexokinase. J Biol Chem. 210:1954;581-595.
27. 125I]iodoethenyl)-D-allose A new strategy for preparation of in vivo stable radioiodinated carbohydrates. NUC Compact. 21:1990;64-69.
28. 123I- analogues of D-glucose as potential radiopharmaceuticals. J Labelled Compd Radiopharm. 19:1981;1626-1628.
29. Bessell E.M., Foster A.B., Westwood J.H. The use of deoxyfluoro-D- glucopyranoses and related compounds in a study of yeast hexokinase specificity. Biochem J. 128:1972;199-204.
30. Goodman M.M., Kabalka G.W., Meng X., Daniel G.B., Longford C.P.D. Synthesis and evaluation of radioiodinated 4-0-(E)-3-iodopropen-2-yl-D-glucose and derivatives as potential heart imaging agents. J Nucl Med. 31:1990;900. (Abstract).
31. Barnett J.E.G., Holman G.D., Chalkley R.A., Munday K.A. Evidence for two asymmetric conformational states in the human erythrocyte sugar-transport system. Biochem J. 145:1975;417-429.
32. Barnett J.E.G., Holman G.D., Munday K.A. Structural requirements for binding to the sugar-transport system of the human erythrocyte. Biochem J. 131:1973;211-221.
33. Hamant S., Mathieu J.-P., Morin C., Trimcev I., Vidal M. The β-iodoethoxyl group a stable unit for radioiodination. Bioorg Med Chem Letters. 4:1994;1687-1690.
34. nd). 2:1979;119-128.
35. Blériot Y., Veighey C.R., Smelt K.H., Cadefau J., Stalmans W., Biggadike K., Lane A.L., Muller M., Watkin D.J., Fleet G.W.J. The first example of a 6-C-aryl-D-glucose inhibition of glucokinase. Tetrahedron: Asymm. 7:1996;2761-2772.